In the phase 2b trial, however, the reductions in glycated hemoglobin and body weight in participants treated with NNC0090-2746 were similar to those in the group treated with liraglutide (76), and no phase 3 trial of NNC0090-2746 has been reported yet
Michael, Brown-Frandsen Kirstine, Colhoun Helen M., et al
Et surtout, que se passe-t-il lorsque nos rserves spuisent
This is not a failure of willpower its biology
Patients with type 2 diabetes who stop using Ozempic can face an increase in blood sugar levels and its accompanied complications (Blum, 2023)
The results suggest that BPC-157 may have improved functional recovery, as indicated by a potential increase in AFI values at all time points